Cargando…

Protective Immune Response against Bacillus anthracis Induced by Intranasal Introduction of a Recombinant Adenovirus Expressing the Protective Antigen Fused to the Fc-fragment of IgG2a

Anthrax is a particularly dangerous infectious disease that affects humans and livestock. It is characterized by intoxication, serosanguineous skin lesions, development of lymph nodes and internal organs, and may manifest itsself in either a cutaneous or septic form. The pathogenic agent is Bacillus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shcherbinin, D. N., Esmagambetov, I. B., Noskov, A. N., Selyaninov, Yu. O., Tutykhina, I. L., Shmarov, M. M., Logunov, D. Yu., Naroditskiy, B. S., Gintsburg, A. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	A.I. Gordeyev 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999469/ https://www.ncbi.nlm.nih.gov/pubmed/24772330

Ejemplares similares

Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection
por: Voronina, Daria V., et al.
Publicado: (2022)

Camelid VHHs Fused to Human Fc Fragments Provide Long Term Protection Against Botulinum Neurotoxin A in Mice
por: Godakova, Svetlana A., et al.
Publicado: (2019)

Construction of a pIX-modified Adenovirus Vector Able to Effectively Bind to Nanoantibodies for Targeting
por: Garas, M. N., et al.
Publicado: (2014)

Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts
por: Tutykhina, Irina, et al.
Publicado: (2018)

The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin
por: Shcherbinin, D.N., et al.
Publicado: (2016)

Induction of a Protective Heterosubtypic Immune Response Against the Influenza Virus by using Recombinant Adenoviral Vectors Expressing Hemagglutinin of the Influenza H5 Virus
por: Shmarov, M.M., et al.
Publicado: (2010)

Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against Chlamydia muridarum Intravaginal Infection
por: Koroleva, Ekaterina A., et al.
Publicado: (2017)

Effective Genetic Expression of Nanoantibodies by Recombinant Adenoviral Vector in vitro
por: Gribova, I.Yu., et al.
Publicado: (2011)

Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis
por: Burmistrova, Daria A., et al.
Publicado: (2016)

An Efficient Method for the Delivery of the Interleukin-2 Gene to Human Hematopoietic Cells using the  Fiber-Modified Recombinant Adenovirus
por: Rogozhin, V.N., et al.
Publicado: (2011)

The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector
por: Lebedeva, Ekaterina, et al.
Publicado: (2018)

Regulation of the Target Protein (Transgene) Expression in the Adenovirus Vector Using Agonists of Toll-Like Receptors
por: Bagaev, A. V., et al.
Publicado: (2014)

Recombinant Influenza Vaccines
por: Sedova, E.S., et al.
Publicado: (2012)

rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis
por: Derkaev, Artem A., et al.
Publicado: (2022)

Plasmacytoid Dendritic Cells Contribute to the Protective Immunity Induced by Intranasal Treatment with Fc-fused Interleukin-7 against Lethal Influenza Virus Infection
por: Kang, Moon Cheol, et al.
Publicado: (2017)

Erratum: Plasmacytoid Dendritic Cells Contribute to the Protective Immunity Induced by Intranasal Treatment with Fc-fused Interleukin-7 against Lethal Influenza Virus Infection
por: Kang, Moon Cheol, et al.
Publicado: (2017)

Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A
por: Panova, Eugenia A., et al.
Publicado: (2023)

Toll-Like Receptors (TLRs): The Role in Tumor Progression
por: Shcheblyakov, D.V., et al.
Publicado: (2010)

Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal challenge with pneumonia virus of mice
por: Maunder, Helen E., et al.
Publicado: (2015)

Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates
por: Tukhvatulin, Amir I., et al.
Publicado: (2022)

Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection
por: Esmagambetov, I. B., et al.
Publicado: (2021)

Preclinical Studies of Immunogenity, Protectivity, and Safety of the Combined Vector Vaccine for Prevention of the Middle East Respiratory Syndrome
por: Dolzhikova, I. V., et al.
Publicado: (2020)

Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis
por: Xing, Zhou, et al.
Publicado: (2009)

Development of Neutralizing Nanobodies to the Hemagglutinin Stem Domain of Influenza A Viruses
por: Voronina, D. V., et al.
Publicado: (2021)

Petrobactin Protects against Oxidative Stress and Enhances Sporulation Efficiency in Bacillus anthracis Sterne
por: Hagan, Ada K., et al.
Publicado: (2018)

Activity of the Bacillus anthracis 20 kDa protective antigen component
por: Hammamieh, Rasha, et al.
Publicado: (2008)

Single intranasal immunization with chimpanzee adenovirus-based vaccine induces sustained and protective immunity against MERS-CoV infection
por: Jia, Wenxu, et al.
Publicado: (2019)

A In Vitro and In Vivo Study of the Ability of NOD1 Ligands to Activate the Transcriptional Factor NF-kB
por: Tukhvatulin, A.I., et al.
Publicado: (2011)

BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine
por: Perera, Dilhan J., et al.
Publicado: (2023)

Single-dose Intranasal Delivery with DEF201 (Adenovirus Vectored Mouse Interferon-α) Protects Against Phlebovirus and Sars Coronavirus Challenge
por: Gowen, Brian, et al.
Publicado: (2010)

A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques
por: Hassan, Ahmed O., et al.
Publicado: (2021)

A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
por: Bricker, Traci L., et al.
Publicado: (2021)

Evaluation of Direct and Cell-Mediated Lactoferrin Gene Therapy for the Maxillofacial Area Abscesses in Rats
por: Agatieva, Elima, et al.
Publicado: (2021)

Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
por: Voß, Franziska, et al.
Publicado: (2018)

Screening of Peptide Libraries against Protective Antigen of Bacillus anthracis in a Disposable Microfluidic Cartridge
por: Kogot, Joshua M., et al.
Publicado: (2011)

Very Early Blood Diffusion of the Active Lethal and Edema Factors of Bacillus anthracis After Intranasal Infection
por: Rougeaux, Clémence, et al.
Publicado: (2020)

Soluble Expression and Characterization of Biologically Active Bacillus anthracis Protective Antigen in Escherichia coli
por: Suryanarayana, Nagendra, et al.
Publicado: (2016)

Preparation and Evaluation of Human-Murine Chimeric Antibody against Protective Antigen of Bacillus anthracis
por: Hao, Lina, et al.
Publicado: (2014)

The protective immunity induced by intranasally inoculated serotype 63 chimpanzee adenovirus vector expressing human respiratory syncytial virus prefusion fusion glycoprotein in BALB/c mice
por: Huang, Lei, et al.
Publicado: (2022)

Sputnik Light and Sputnik V Vaccination Is Effective at Protecting Medical Personnel from COVID-19 during the Period of Delta Variant Dominance
por: Sukhikh, Gennady T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m00a4s363etvnf04bmi60g3jvb